Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis

ClinicalTrials.gov ID: NCT00408629

Public ClinicalTrials.gov record NCT00408629. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 1:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Moderately to Severely Active Ulcerative Colitis

Study identification

NCT ID
NCT00408629
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott
Industry
Enrollment
518 participants

Conditions and interventions

Interventions

  • adalimumab Biological
  • placebo Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2006
Primary completion
Feb 28, 2010
Completion
Feb 28, 2010
Last update posted
May 2, 2011

2006 – 2010

United States locations

U.S. sites
36
U.S. states
21
U.S. cities
32
Facility City State ZIP Site status
Site Ref # / Investigator 5394 Anaheim California 92801
Site Ref # / Investigator 3753 Wheat Ridge Colorado 80033
Site Ref # / Investigator 3754 Hamden Connecticut 06518
Site Ref # / Investigator 12903 Gainesville Florida 32607
Site Ref # / Investigator 3747 Hollywood Florida 33021
Site Ref # / Investigator 5106 Jacksonville Florida 32256
Site Ref # / Investigator 11601 Naples Florida 34102
Site Ref # / Investigator 6846 Sarasota Florida 34239
Site Ref # / Investigator 3742 Winter Park Florida 32789
Site Ref # / Investigator 3760 Zephyrhills Florida 33542
Site Ref # / Investigator 3739 Atlanta Georgia 30342
Site Ref # / Investigator 7658 Macon Georgia 31201
Site Ref # / Investigator 5397 Moline Illinois 61265
Site Ref # / Investigator 7453 Topeka Kansas 66606
Site Ref # / Investigator 3759 Annapolis Maryland 21401
Site Ref # / Investigator 3762 Annapolis Maryland 21401
Site Ref # / Investigator 3738 Lutherville Maryland 21093
Site Ref # / Investigator 7472 Troy Michigan 48098
Site Ref # / Investigator 3744 Rochester Minnesota 55905
Site Ref # / Investigator 6088 St Louis Missouri 63128
Site Ref # / Investigator 3756 Great Neck New York 11021
Site Ref # / Investigator 3752 Charlotte North Carolina 28207
Site Ref # / Investigator 3758 Jacksonville North Carolina 28546
Site Ref # / Investigator 3745 Cincinnati Ohio 45219
Site Ref # / Investigator 7709 Oklahoma City Oklahoma 73104
Site Ref # / Investigator 3740 Tulsa Oklahoma 74104
Site Ref # / Investigator 3765 Sayre Pennsylvania 18840
Site Ref # / Investigator 3741 Columbia South Carolina 29204
Site Ref # / Investigator 3737 Germantown Tennessee 38138
Site Ref # / Investigator 6077 Nashville Tennessee 37203
Site Ref # / Investigator 5107 Nashville Tennessee 37205
Site Ref # / Investigator 3743 Nashville Tennessee 37212-1610
Site Ref # / Investigator 5398 Ogden Utah 84405
Site Ref # / Investigator 8064 Spokane Washington 99202
Site Ref # / Investigator 3750 Spokane Washington 99204
Site Ref # / Investigator 3761 West Bend Wisconsin 53095

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 72 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00408629, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 2, 2011 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00408629 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →